Zulassung von genomeditierten Nutzpflanzen in der Schweiz

Published: 1 January 2021

Regulierungsoptionen unter Berücksichtigung der Zulassungssysteme in der Europäischen Union und den Vereinigten Staaten von Amerika, Zurich 2021

Deals & Cases — 11.05.2026

McKay Brothers Secures Level Playing Field

Deals & Cases — 11.05.2026

Launch of Internet Archive Switzerland

Insights – 29.05.2026

Swiss Federal Supreme Court rules that shareholders have no say on asset sales in composition proceedings

Swiss Federal Supreme Court rules that shareholders have no say on asset…

The Swiss Federal Supreme Court has issued an important decision on asset sales during a composition moratorium. In essence, the court has clarified the following: - Like creditors, shareholders do not have standing to challenge a court's decision on asset sales during a composition moratorium. - If an asset sale occurs during a composition moratorium, no shareholder approval is required even if the sale relates to all or a significant part of the assets of a company. The decision removes legal uncertainty and will be helpful to structure and implement pre-pack and other asset disposal transactions under time pressure.

Insights – 21.05.2026

Institutional Reform of the Swiss Competition Commission – Proposal of the Federal Council

Institutional Reform of the Swiss Competition Commission – Proposal of the…